Percentage of Her2 positive cells in immunohistochemistry-equivocal (2+) invasive breast cancer and its significance as a predictive value for the amplification status

被引：0
|
作者：
Marras, V. [1 ]
Satta, G. [1 ]
Fedeli, M. A. [1 ]
Trombetta, M. [1 ]
Lako, K. [1 ]
Meloni, M. [1 ]
Fara, A. M. [1 ]
Camboni, A. C. [1 ]
Doneddu, V. [1 ]
Manca, A. [1 ]
Tanda, F. [1 ]
机构：
[1] AOU Sassari, UO Anat Patol, Sassari, Italy
来源：
VIRCHOWS ARCHIV | 2017年 / 471卷
关键词：
D O I：
暂无
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
PS-01-034
引用
收藏
页码：S58 / S58
页数：1
相关论文
共 50 条
  • [1] Clinicopathological variables predicting HER-2 gene status in immunohistochemistry-equivocal (2+) invasive breast cancer
    Ji, Yongling
    Sheng, Liming
    Du, Xianghui
    Qiu, Guoqin
    Chen, Bo
    Wang, Xiaojia
    JOURNAL OF THORACIC DISEASE, 2014, 6 (07) : 896 - 904
  • [2] The role of HER2 gene copy number variations in immunohistochemistry-equivocal (2+) breast cancer
    Kocsmar, I.
    Tokes, A. M.
    Kafer, D.
    Kocsmar, E.
    Kristof, K. Attila
    Kulka, J.
    Lotz, G.
    VIRCHOWS ARCHIV, 2020, 477 : S225 - S225
  • [3] Predicting factor for HER-2 gene status in immunohistochemistry-equivocal (2+) breast cancer
    Kim, S. K.
    Kang, S. Y.
    Youn, H. J.
    Jung, S. H.
    BREAST, 2015, 24 : S62 - S62
  • [4] The relation between percentage of immunostained cells and amplification status in breast cancers with equivocal result for Her2 immunohistochemistry
    Onguru, Onder
    Zhang, Paul J.
    PATHOLOGY RESEARCH AND PRACTICE, 2016, 212 (05) : 381 - 384
  • [5] Correlation of immunohistochemistry-equivocal (2+) human epidermal growth factor receptor 2 (HER2) with fluorescence in situ hybridization (FISH) gene status in invasive breast cancer: Is FISH necessary for all HER2 equivocal breast cancer cases?
    Alswayyed, Mohammed
    KUWAIT MEDICAL JOURNAL, 2022, 54 (04): : 476 - 480
  • [6] Using Machine Learning to Predict Final HER2 Status in Invasive Breast Cancer Cases that are Equivocal (2+) by Immunohistochemistry
    Rasmussen, Sean
    Taylor, Valerie
    Surette, Alexi
    Barnes, Penny
    Bethune, Gillian
    MODERN PATHOLOGY, 2022, 35 (SUPPL 2) : 182 - 182
  • [7] Using Machine Learning to Predict Final HER2 Status in Invasive Breast Cancer Cases that are Equivocal (2+) by Immunohistochemistry
    Rasmussen, Sean
    Taylor, Valerie
    Surette, Alexi
    Barnes, Penny
    Bethune, Gillian
    LABORATORY INVESTIGATION, 2022, 102 (SUPPL 1) : 182 - 182
  • [8] Breast carcinomas with borderline (2+) HER2 immunohistochemistry: percentage of cells with complete membrane staining for HER2 and the frequency of HER2 amplification
    Lee, Andrew H. S.
    Key, Heather P.
    Bell, Jane A.
    Hodi, Zsolt
    Ellis, Ian O.
    JOURNAL OF CLINICAL PATHOLOGY, 2011, 64 (06) : 490 - 492
  • [9] Significance of Percentage of 2+IHC Positive Cells for the Prediction of HER2 Amplification Status in Breast Cancers
    Onguru, Onder
    Zhang, Paul
    LABORATORY INVESTIGATION, 2015, 95 : 59A - 59A
  • [10] Significance of Percentage of 2+IHC Positive Cells for the Prediction of HER2 Amplification Status in Breast Cancers
    Onguru, Onder
    Zhang, Paul
    MODERN PATHOLOGY, 2015, 28 : 59A - 59A
12345